Taking into account the thematic focus of our article, which is the modulation of antitumor immune responses, it should only be briefly mentioned here that for IL-17A, the ability to increase tumor cell growth and tumor-associated neoangiogenesis has been described in the context of CRC, whereas IL-17F seems to influence both processes in the opposite direction [72]. Here, IL17A is linked to neoplasm.